文献速递主动脉疾病

EVAR失败后开放手术转换的早中期结局:INTRICATE注册研究

Early and midterm outcomes following open surgical conversion after failed endovascular aneurysm repair from the "Italian North-easT RegIstry of surgical Conversion AfTer Evar" (INTRICATE).
PubMed 文献 · J Vasc Surg · 2021-06-26

基于意大利东北部八家中心的多中心注册数据,回顾性分析144例EVAR失败后行开放手术转换的患者。内漏是最常见指征(50.7%),30天全因死亡率为13.9%,22.2%发生至少一种主要并发症。急诊手术、肾上/腹腔干阻断及移植物感染与更差生存相关。

要点

  • EVAR失败后开放转换的30天死亡率为13.9%,主要并发症发生率22.2%。
  • 年龄、肾阻断时间及肾上/腹腔干阻断是围术期主要并发症的独立预测因素。
  • 急诊手术及肾上型阻断与5年生存率显著降低相关。

核心结论

  • EVAR失败后开放手术转换与较高的早期并发症和死亡率相关,尤其在急诊手术时。
  • 内漏伴瘤囊二次扩张是开放转换的主要指征,常需肾上型主动脉阻断。
  • 移植物感染和急诊治疗与较差的短期和长期生存相关。

主要发现

  • 开放转换指征:内漏50.7%,移植物感染24.6%,闭塞21.9%。
  • 30天全因死亡率为13.9%(n=20),32例(22.2%)发生至少一种主要并发症,平均住院日13±12.7天。
  • 肾阻断时间>25分钟预测主要不良事件的敏感性65%、特异性70%(AUC 0.72,95%CI 0.61-0.82)。

临床怎么用

  • 对EVAR失败需开放转换者,应评估年龄、阻断部位及肾阻断时间以预判围术期风险。
  • 肾上/腹腔干阻断及急诊手术与更差生存相关,术前规划应尽量优化阻断策略和手术时机。
  • 肾阻断时间>25分钟对主要不良事件有一定预测价值,可辅助术后监护决策。

局限性

  • 回顾性研究设计,存在选择偏倚和信息偏倚可能。
  • 样本来自同一地理区域的多中心,外推性需谨慎。
  • 原文未报告部分亚组的具体样本量及多因素模型中年龄的效应值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report the early and mid-term outcomes following open surgical conversion (OSC) after failed endovascular aortic repair (EVAR) using data from a multicentric registry. METHODS: A retrospective study was carried out on consecutive patients undergoing OSC after failed EVAR at eight tertiary vascular units from the same geographic area in the North-East of Italy, from April 2005 to November 2019. Study endpoints included early and follow-up outcomes. RESULTS: A total of 144 consecutive patients were included in the study. Endoleaks were the most common indication for OSC (50.7%), with endograft infection (24.6%) and occlusion (21.9%) being the second most prevalent causes. The overall rate of 30-day all-cause mortality was 13.9% (n = 20); 32 patients (22.2%) experienced at least one major complication. Mean length of stay was 13 ± 12.7 days. On multivariate logistic regression, age (odds ratio [OR], 1.09; 95% confidence interval [CI], 1.01-1-19; P = .02), renal clamping time (OR, 1.07; 95% CI, 1.02-1.13; P = .01), and suprarenal/celiac clamping (OR, 6.66; 95% CI, 1.81-27.1; P = .005) were identified as independent predictors of perioperative major complications. Age was the only factor associated with perioperative mortality at 30 days. Renal clamping time >25 minutes had sensitivity of 65% and specificity of 70% in predicting the occurring of major adverse events (area under the curve, 0.72; 95% CI, 0.61-0.82). At 5 years, estimated survival was significantly lower for patients treated due to aortic rupture/dissection (28%; 95% CI, 13%-61%), compared with patients in whom the indication for treatment was endoleak (54%; 95% CI, 40%-73%), infection (53%; 95% CI, 30%-94%), or thrombosis (82%; 95% CI, 62%-100%; P = .0019). Five-year survival rates were significantly lower in patients who received emergent treatment (28%; 95% CI, 14%-55%) as compared with those who were treated in an urgent (67%; 95% CI, 48%-93%) or elective setting (57%; 95% CI, 43%-76%; P = .00026). Subjects who received suprarenal/celiac (54%; 95% CI, 36%-82%) or suprarenal (46%; 95% CI, 34%-62%) aortic cross-clamping had lower survival rates at 5 years than those whose aortic-cross clamp site was infrarenal (76%; 95% CI, 59%-97%; P = .041). Using multivariate Cox proportional hazard, older age and emergency setting were independently associated with higher risk for overall 5-year mortality. CONCLUSIONS: OSC after failed EVAR was associated with relatively high rates of early morbidity and mortality, particularly for emergency setting surgery. Endoleaks with secondary sac expansion were the main indication for OSC, and suprarenal aortic cross-clamping was frequently required. Endograft infection and emergent treatment remained associated with poorer short- and long-term survival.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Xodo A, D'Oria M, Squizzato F, et al. Early and midterm outcomes following open surgical conversion after failed endovascular aneurysm repair from the "Italian North-easT RegIstry of surgical Conversion AfTer Evar" (INTRICATE). J Vasc Surg. 2021. PMID: 34182022. doi:10.1016/j.jvs.2021.05.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。